| Literature DB >> 34535107 |
Jonathan Mathias Baier1, Kristian Løkke Funck2, Liv Vernstrøm2, Esben Laugesen2, Per Løgstrup Poulsen2.
Abstract
BACKGROUND: The long-term association between physical activity and endothelial function has not previously been investigated in patients with type 2 diabetes. Therefore, we aimed to evaluate the relationship between physical activity and endothelial function, assessed by peripheral arterial tonometry, in patients with type 2 diabetes and non-diabetic controls after 5 years of follow-up.Entities:
Keywords: Accelerometery; EndoPAT; Endothelial dysfunction; Endothelial function; Peripheral arterial tonometry; Physical activity; Reactive hyperemia index; Type 2 diabetes
Mesh:
Substances:
Year: 2021 PMID: 34535107 PMCID: PMC8449475 DOI: 10.1186/s12902-021-00857-9
Source DB: PubMed Journal: BMC Endocr Disord ISSN: 1472-6823 Impact factor: 2.763
Clinical and biochemical characteristics of the study population. All baseline characteristics are from time of enrolment
| Characteristic | T2DM ( | Controls ( | |
|---|---|---|---|
| Age, years | 64.5 ± 9.7 | 63.2 ± 9.9 | 0.75 |
| Male sex, n (%) | 30 (59) | 28 (53) | 0.54 |
| Diabetes duration at baseline, years | 1.9 (1.0;3.3) | n/a | n/a |
| 24 h blood pressure, mmHg | |||
| Systolic | 126 ± 10a | 124 ± 11b | 0.84 |
| Diastolic | 75 ± 7a | 75 ± 7b | 0.46 |
| Office blood pressure, mmHg | |||
| Systolic | 127 ± 11c | 131 ± 15 | 0.08 |
| Diastolic | 80 ± 8c | 83 ± 10 | 0.03 |
| Heart rate (beats/minute) | 65 ± 10d | 60 ± 9 | 0.997 |
| BMI, kg/m2 | 29.9 ± 4.7 | 26.3 ± 3.8 | < 0.001 |
| Smoking status | 0.38 | ||
| Current, | 9 (18) | 7 (13) | |
| Former | 21 (41) | 17 (32) | |
| Never, | 21 (41) | 29 (55) | |
| Previous CVD, | 11 (22) | 6 (11) | 0.12 |
| Daytime physical activity (cpm) | 27 ± 15 | 42 ± 19 | < 0.001 |
| HbA1C. mmol/mol | 48 ± 8 | 38 ± 4 | n/a |
| HbA1C, (%) | 6.5 ± 0.7 | 5.7 ± 0.3 | n/a |
| Total cholesterol, mmol/L | 4.3 ± 0.8 | 5.7 ± 1.0 | < 0.001 |
| HDL-C, mmol/L | 1.4 ± 0.3 | 1.7 ± 0.6 | < 0.001 |
| LDL-C, mmol/L | 2.2 ± 0.7e | 3.3 ± 1.0 | < 0.001 |
| Triglycerides, mmol/L | 1.6 (1.0;2.2) | 1.2 (0.9;1.6) | 0.01 |
| UACR, mg/g | 0.46 (0.28;1.04) | 0.23 (0.16;0.34) | < 0.001 |
| Antihypertensive treatment, | 34 (67) | 15 (28) | < 0.001 |
| Diabetes treatment | |||
| Metformin, | 32 (63) | 0 (0) | n/a |
| Sulfonylureas, | 6 (12) | 0 (0) | n/a |
| GLP-1 agonist, | 0 (0) | 0 (0) | n/a |
| DPP4 inhibitor, | 2 (4) | 0 (0) | n/a |
| Insulin, | 4 (8) | 0 (0) | n/a |
| Acetylsalicylic acid, | 32 (63) | 3 (6) | < 0.001 |
| Statin, | 38 (75) | 10 (19) | < 0.001 |
an = 50
bn = 52
cn = 49
dn = 50
en = 49
Fig. 1Daytime physical activity at baseline and endothelial function (lnRHI) after 5 years
Univariate and multivariate linear regression models used to test for association between daytime physical activity and endothelial function
| Linear regression model | Beta (95 %-CI) | |
|---|---|---|
| Crude | 0.003 (0.0006;0.006) | 0.02 |
| Model 1 | 0.003 (0.0005;0.006) | 0.02 |
| Model 2 | 0.003 (0.0002;0.006) | 0.04 |
Beta: Change in lnRHI per daytime activity count
Model 1: Adjusted for age, sex and diabetes
Model 2: Adjusted for age, sex, diabetes, smoking status, 24-h BP, LDL-cholesterol, UACR and BMI